findmyKOL
Clinical trialNCT05019716RecruitingPhase 1/PHASE2Interventional

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

SponsorNational Cancer Institute (NCI)Enrollment36Advanced NUT CarcinomaMetastatic NUT CarcinomaUnresectable NUT Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Los Angeles General Medical Center

    Los Angeles, California, United States

    Robert Hsu
    Recruiting
  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

    Robert Hsu
    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Jia Luo
    Recruiting
  • University of Pittsburgh Cancer Institute (upci)

    Pittsburgh, Pennsylvania, United States

    Liza C. Villaruz
    Recruiting
  • Ut Md Anderson Cancer Center

    Houston, Texas, United States

    Sarina A. Piha-Paul
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Jul 2022
Primary completion
30 Jun 2026
Completion
30 Jun 2026
Last update posted
17 Jun 2026
Registered enrollment
36
Registry id
NCT05019716
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.